Area of research
Hematology · Epidemiology
Research interest
Research interests include Sepsis Diagnosis and Treatment, Autoimmune and Inflammatory Disorders Research, Immunodeficiency and Autoimmune Disorders, and COVID-19 Clinical Research Studies.
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited
Hyperferritinemia Screening to Aid Identification and Differentiation of Patients with Hyperinflammatory Disorders
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
The 2022 <scp>EULAR</scp>/<scp>ACR</scp> Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (<scp>HLH</scp>/<scp>MAS</scp>)
Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric research network: a causal inference analysis
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3
Machine learning derivation of four computable 24-h pediatric sepsis phenotypes to facilitate enrollment in early personalized anti-inflammatory clinical trials
Mortality Risk in Pediatric Sepsis Based on C-reactive Protein and Ferritin Levels
Prevalence of Pathogenic and Potentially Pathogenic Inborn Error of Immunity Associated Variants in Children with Severe Sepsis
On the Alert for Cytokine Storm: Immunopathology in <scp>COVID</scp>‐19
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2
Hyperferritinemia and inflammation